Janus Henderson Group PLC Sells 631 Shares of Semler Scientific, Inc. (NASDAQ:SMLR)

Janus Henderson Group PLC cut its stake in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 3.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 19,510 shares of the company’s stock after selling 631 shares during the quarter. Janus Henderson Group PLC owned about 0.27% of Semler Scientific worth $459,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. CWM LLC raised its holdings in Semler Scientific by 486.3% in the 2nd quarter. CWM LLC now owns 897 shares of the company’s stock worth $31,000 after acquiring an additional 744 shares during the last quarter. Newbridge Financial Services Group Inc. bought a new stake in shares of Semler Scientific in the 2nd quarter worth $34,000. Quest Partners LLC purchased a new position in shares of Semler Scientific in the second quarter worth $59,000. Meeder Asset Management Inc. purchased a new stake in shares of Semler Scientific during the second quarter valued at $67,000. Finally, US Bancorp DE increased its holdings in Semler Scientific by 60.8% in the 3rd quarter. US Bancorp DE now owns 3,064 shares of the company’s stock worth $72,000 after buying an additional 1,158 shares in the last quarter. Hedge funds and other institutional investors own 49.37% of the company’s stock.

Semler Scientific Stock Performance

Shares of NASDAQ:SMLR opened at $67.17 on Monday. The business has a 50-day simple moving average of $43.82 and a two-hundred day simple moving average of $34.81. The firm has a market cap of $556.84 million, a price-to-earnings ratio of 32.77 and a beta of 1.18. Semler Scientific, Inc. has a fifty-two week low of $20.88 and a fifty-two week high of $79.45.

Semler Scientific (NASDAQ:SMLR) last released its quarterly earnings data on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The firm had revenue of $13.51 million during the quarter.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.